HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Genichi Sakaguchi Kazunobu Nishimura Masashi Komeda Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sakakibara, Y. Articles by Komeda, M. Search for Related Content PubMed PubMed Citation Articles by Sakakibara, Y. Articles by Komeda, M. Related Collections Coronary disease Myocardial infarction

Eur J Cardiothorac Surg 2003;24:105-112
© 2003 Elsevier Science NL

Toward surgical angiogenesis using slow-released basic fibroblast growth factor

^a Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
^b Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan

Received 28 September 2002; received in revised form 3 March 2003; accepted 7 March 2003.

^* Corresponding author. Tel.: +81-75-751-3780; fax: +81-75-751-3098
e-mail: masakom{at}kuhp.kyoto-u.ac.jp

Objective: Therapeutic angiogenesis using basic fibroblast growth factor (bFGF) in coronary artery disease has been documented in a number of papers. However, the effectiveness is discrepant among documents. In this study, we evaluated the distribution of bFGF in the rat heart by different administration methods, and investigated the efficacy of slow-released administration of bFGF using biodegradable hydrogel microspheres (bFGF microspheres) in a pig infarction model toward an enhanced coronary bypass surgery. Methods: Heart failure due to myocardial infarction was induced in rats and pigs. In the rat study, free form of bFGF (central venous injection, intracoronary injection, and intramyocardial administration) and bFGF microspheres (intramyocardial administration) were given 4 weeks later. The remaining radioactivity of bFGF in the hearts was estimated 1, 24, and 72 h later. On the other hand, the pigs were randomized into two groups 4 weeks after myocardial infarction. While the control group (n=8) had gelatin hydrogel microspheres with saline, the FGF group (n=8) received bFGF microspheres in the left ventricular (LV) wall. Results: In the rat study, after intramyocardial administration of bFGF microspheres, more bFGF remained in the rat heart 72 h later compared with the other methods (P<0.0001). In the pig study, 4 weeks after the treatment, the FGF group had smaller LV diastolic diameter (48.7±5.3 vs. 56.7±5.2 mm, P<0.01) than the control group. LV end-systolic elastance was higher in the FGF group (2.96±1.2 vs. 1.06±0.3 mmHg/ml, P<0.01). In microscopic examinations, many neovessels were found in and around the scar tissue, and the vascular density in the FGF group was significantly higher (61.5±18.3 vs. 153.0±29.0/mm², P<0.01). In addition, the infarcted LV walls were less expanded and more thickened in the FGF group. Conclusions: Biodegradable hydrogel microspheres with bFGF improved LV function and inhibited LV remodeling by angiogenesis in pigs with chronic myocardial infarction. bFGF microspheres into ischemic myocardium may revascularize small ungraftable vessels and may potentially increase distal run-off when applied in coronary bypass surgery.

Key Words: Angiogenesis • Basic fibroblast growth factor • Myocardial infarction

This article has been cited by other articles:

				S. Apostolakis, G. Y.H. Lip, and E. Shantsila Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovasc Res, October 28, 2009; (2009) cvp327v2. [Abstract] [Full Text] [PDF]

				A. Seko, N. Nitta, A. Sonoda, S. Ohta, M. Takahashi, K. Murata, and Y. Tabata Vascular Regeneration by Repeated Infusions of Basic Fibroblast Growth Factor in a Rabbit Model of Hind-Limb Ischemia Am. J. Roentgenol., June 1, 2009; 192(6): W306 - W310. [Abstract] [Full Text] [PDF]

				H. Lee, H. J. Chung, and T. G. Park Perspectives On: Local and Sustained Delivery of Angiogenic Growth Factors Journal of Bioactive and Compatible Polymers, January 1, 2007; 22(1): 89 - 114. [Abstract] [PDF]

				Y. Liu, L. Sun, Y. Huan, H. Zhao, and J. Deng Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 103 - 107. [Abstract] [Full Text] [PDF]